Crop Life Science Ltd.
•Add ratio to table
ABOUT
KEY POINTS
Revenue Breakup Mar 2025 • Agro Chemicals: 100.0%
AI Sector View
AI GENERATEDChemicals
The available domestic chemical proxies are mixed to weak. Fertilizers output was -8.0% YoY (2026-07) and sale quantity of fertilisers was 0.0% YoY (2026-05), although that high-frequency barometer is stale. FPI positioning is less negative than before, with net 3-month outflow only INR -11 crore versus INR -1229 crore in the prior 3 months to 2026-08-31, but the weak sector driver argues for a neutral stance.
PROS
CONS
- Operating cash flow has been negative in recent years
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -0.52x)
- Company has a low return on equity of 9.4% over last 3 years
- Free cash flow has been persistently negative
- Though reporting repeated profits, the company pays out little dividend (0.0%)
- Debtor days have increased from 101 to 133
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
| Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| UPL | 573.85 | 23.98 | 48442.66 | 1.05 | -73.00 | 58.52 | 10181.00 | 10.47 | 12.00 | 13.43 |
| PIIND | 2257.50 | 29.40 | 34250.37 | 0.66 | 244.20 | -38.95 | 1702.30 | -10.43 | 16.00 | 21.69 |
| SUMICHEM | 477.00 | 41.09 | 23809.25 | 0.27 | 214.51 | 20.45 | 1063.35 | 0.62 | 23.39 | 21.94 |
| BAYERCROP | 3980.00 | 322.82 | 17886.95 | 3.77 | 321.60 | 15.39 | 1835.00 | -4.16 | 30.08 | 20.03 |
| SHARDACROP | 766.05 | 11.04 | 6911.34 | 1.96 | 88.02 | -38.36 | 1073.77 | 9.03 | 31.10 | 17.32 |
| DHANUKA | 980.30 | 14.72 | 4370.01 | 0.20 | 75.50 | 27.94 | 442.02 | 20.01 | 24.44 | 24.83 |
| RALLIS | 202.00 | 23.92 | 3928.27 | 1.49 | -14.15 | -274.26 | 507.54 | 7.70 | 13.23 | -0.56 |
| NACLIND | 157.65 | 298.53 | 3692.85 | 0.00 | 20.84 | 59.82 | 383.33 | -14.50 | 6.20 | 10.80 |
| BHAGCHEM | 257.45 | 121.29 | 3338.33 | 0.06 | 133.29 | 3249.84 | 1950.19 | 1475.55 | 4.55 | 15.65 |
| GSPCROP | 471.50 | 22.41 | 2193.36 | 0.21 | 263.94 | 1111.46 | 3859.95 | 1153.27 | 18.46 | 11.02 |
| BHARATRAS | 1157.60 | 13.43 | 1924.06 | 0.04 | 372.30 | 838.73 | 3381.60 | 796.03 | 16.63 | 15.19 |
| CLSL | 83.00 | 21.44 | 142.26 | 0.00 | — | — | — | — | 11.35 | — |
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
No quarterly results found
We don't have this information yet. Please check back later.
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 131 | 199 | 201 | |
| 119 | 186 | 185 | |
| Operating Profit | 12 | 13 | 16 |
| OPM % | 8.97% | 6.35% | 7.75% |
| 1 | 2 | 2 | |
| Interest | 3 | 3 | 5 |
| Depreciation | 4 | 3 | 5 |
| Profit before Tax | 6 | 8 | 8 |
| Tax % | 27.26% | 25.79% | 28.15% |
| Net Profit | 4 | 6 | 6 |
| EPS | 3.39 | 3.51 | 3.44 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% |
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- 23%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 9%
- Last Year:
- 8%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Equity Capital | 12 | 17 | 17 |
| Minority Interest | 0 | 4 | 4 |
| 29 | 55 | 60 | |
| 24 | 33 | 41 | |
| Trade Payables | 20 | 53 | 42 |
| 19 | 20 | 21 | |
| Total Liabilities | 103 | 182 | 184 |
| 16 | 39 | 38 | |
| 0 | 0 | 1 | |
| 26 | 40 | 49 | |
| 0 | 77 | 69 | |
| Cash & Bank | 0 | 2 | 1 |
| 61 | 23 | 26 | |
| Total Assets | 103 | 182 | 184 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 4 | -8 | -2 | |
| Cash from Investing | -4 | -3 | -4 |
| Cash from Financing | 1 | 13 | 4 |
| -2 | 2 | -1 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
Documents
Corporate disclosures, annual reports, credit ratings, and concall transcripts
No announcements filed.
News
Recent coverage and analyst commentary for CLSL
Loading news…
AI Stock Analyst
Crop Life Science Ltd.
Sign in to Chat with AI
Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.
✨ Sign In to ChatFree 5nance Account